IL175253A0 - A process for preparing pyrrole derivatives - Google Patents
A process for preparing pyrrole derivativesInfo
- Publication number
- IL175253A0 IL175253A0 IL175253A IL17525306A IL175253A0 IL 175253 A0 IL175253 A0 IL 175253A0 IL 175253 A IL175253 A IL 175253A IL 17525306 A IL17525306 A IL 17525306A IL 175253 A0 IL175253 A0 IL 175253A0
- Authority
- IL
- Israel
- Prior art keywords
- pyrrole derivatives
- preparing pyrrole
- preparing
- derivatives
- pyrrole
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000003233 pyrroles Chemical class 0.000 title 1
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51528303P | 2003-10-28 | 2003-10-28 | |
| PCT/US2004/037985 WO2005042484A1 (en) | 2003-10-28 | 2004-10-28 | Preparation of 4,5-dialkyl-3-acyl-pyrrole-2-carboxylic acid derivatives by fischer-fink type synthesis and subsequent acylation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL175253A0 true IL175253A0 (en) | 2006-09-05 |
Family
ID=34549387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL175253A IL175253A0 (en) | 2003-10-28 | 2006-04-27 | A process for preparing pyrrole derivatives |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7250520B2 (enExample) |
| EP (1) | EP1678134B1 (enExample) |
| JP (2) | JP4942485B2 (enExample) |
| KR (1) | KR20060122872A (enExample) |
| CN (1) | CN1894211A (enExample) |
| AT (1) | ATE442355T1 (enExample) |
| AU (1) | AU2004285972A1 (enExample) |
| DE (1) | DE602004023105D1 (enExample) |
| ES (1) | ES2330944T3 (enExample) |
| IL (1) | IL175253A0 (enExample) |
| WO (1) | WO2005042484A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA79749C2 (en) | 1996-10-18 | 2007-07-25 | Vertex Pharma | Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| SV2003000617A (es) | 2000-08-31 | 2003-01-13 | Lilly Co Eli | Inhibidores de la proteasa peptidomimetica ref. x-14912m |
| TWI359147B (en) | 2003-09-05 | 2012-03-01 | Vertex Pharma | Inhibitors of serine proteases, particularly hcv n |
| US8399615B2 (en) | 2005-08-19 | 2013-03-19 | Vertex Pharmaceuticals Incorporated | Processes and intermediates |
| AR055395A1 (es) | 2005-08-26 | 2007-08-22 | Vertex Pharma | Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c |
| US7964624B1 (en) | 2005-08-26 | 2011-06-21 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases |
| AU2007217355B2 (en) | 2006-02-27 | 2012-06-21 | Vertex Pharmaceuticals Incorporated | Co-crystals comprising VX-950 and pharmaceutical compositions comprising the same |
| EP2194039A1 (en) | 2006-03-16 | 2010-06-09 | Vertex Pharmceuticals Incorporated | Process for preparing optically enriched compounds |
| CA2679312A1 (en) | 2007-02-27 | 2008-09-04 | Vertex Pharmaceuticals Incorporated | Co-crystals and pharmaceutical compositions comprising the same |
| CN101903392A (zh) | 2007-02-27 | 2010-12-01 | 弗特克斯药品有限公司 | 丝氨酸蛋白酶的抑制剂 |
| WO2009032198A1 (en) | 2007-08-30 | 2009-03-12 | Vertex Pharmaceuticals Incorporated | Co-crystals and pharmaceutical compositions comprising the same |
| EP2489346A1 (en) | 2011-01-26 | 2012-08-22 | NanotecMARIN GmbH | Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases |
| JP2015053226A (ja) | 2013-09-09 | 2015-03-19 | タイコエレクトロニクスジャパン合同会社 | 電気コネクタの端子、及び電気コネクタ |
| US10207974B1 (en) | 2017-12-05 | 2019-02-19 | Chevron Phillips Chemical Company Lp | Synthesis of gamma dicarbonyl and pyrrole compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2481369C (en) | 2002-04-11 | 2012-07-10 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease |
| TW200510391A (en) * | 2003-04-11 | 2005-03-16 | Vertex Pharma | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
-
2004
- 2004-10-28 AT AT04796917T patent/ATE442355T1/de not_active IP Right Cessation
- 2004-10-28 AU AU2004285972A patent/AU2004285972A1/en not_active Abandoned
- 2004-10-28 JP JP2006538556A patent/JP4942485B2/ja not_active Expired - Fee Related
- 2004-10-28 EP EP04796917A patent/EP1678134B1/en not_active Expired - Lifetime
- 2004-10-28 KR KR1020067010241A patent/KR20060122872A/ko not_active Abandoned
- 2004-10-28 DE DE602004023105T patent/DE602004023105D1/de not_active Expired - Lifetime
- 2004-10-28 ES ES04796917T patent/ES2330944T3/es not_active Expired - Lifetime
- 2004-10-28 CN CNA2004800377619A patent/CN1894211A/zh active Pending
- 2004-10-28 WO PCT/US2004/037985 patent/WO2005042484A1/en not_active Ceased
- 2004-10-28 US US10/978,301 patent/US7250520B2/en not_active Expired - Fee Related
-
2006
- 2006-04-27 IL IL175253A patent/IL175253A0/en unknown
-
2007
- 2007-06-13 US US11/762,274 patent/US20080167480A1/en not_active Abandoned
-
2011
- 2011-06-14 JP JP2011131818A patent/JP2011231117A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP4942485B2 (ja) | 2012-05-30 |
| US7250520B2 (en) | 2007-07-31 |
| AU2004285972A1 (en) | 2005-05-12 |
| DE602004023105D1 (de) | 2009-10-22 |
| ES2330944T3 (es) | 2009-12-17 |
| JP2007509991A (ja) | 2007-04-19 |
| CN1894211A (zh) | 2007-01-10 |
| HK1092134A1 (en) | 2007-02-02 |
| WO2005042484A1 (en) | 2005-05-12 |
| US20050143585A1 (en) | 2005-06-30 |
| EP1678134A1 (en) | 2006-07-12 |
| EP1678134B1 (en) | 2009-09-09 |
| US20080167480A1 (en) | 2008-07-10 |
| JP2011231117A (ja) | 2011-11-17 |
| ATE442355T1 (de) | 2009-09-15 |
| KR20060122872A (ko) | 2006-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02012795A (es) | Carvedilol. | |
| TW200508201A (en) | Novel process for the preparation of roflumilast | |
| IL175253A0 (en) | A process for preparing pyrrole derivatives | |
| PT1509517E (pt) | Nova síntese de irbesartan | |
| TW200619215A (en) | Asymmetric synthesis of dihydrobenzofuran derivatives | |
| SG144736A1 (en) | Synthesis of temozolomide and analogs | |
| SG143062A1 (en) | Synthesis of temozolomide and analogs | |
| MXPA05005761A (es) | Proceso para preparar (s)-pantoprazola. | |
| TW200728310A (en) | Process for the preparation of ferri-succinylcasein | |
| TW200800986A (en) | Tetrahydroquinolines, synthesis thereof, and intermediates thereto | |
| TW200738713A (en) | Diazepinoquinolines, synthesis thereof, and intermediates thereto | |
| SI1206452T1 (en) | Novel method for preparing benzoperhydroisoindole compounds | |
| SG146645A1 (en) | Process for the synthesis of 6-amino-4-(3-chloro-4fluoro-phenylamino)-7- ethoxy-quinoline-3-carbonitrile | |
| TW200637832A (en) | Process for preparing amorphous valsartan | |
| TW200420537A (en) | Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination | |
| AU2003300727A1 (en) | Process for synthesis of alpha-substituted acroleins | |
| MX2007013872A (es) | Procedimiento para la produccion de 4-bifenililazetidina-2-onas. | |
| GB0320738D0 (en) | Novel process | |
| IL179141A0 (en) | Biotransformation of colchicinoid compounds | |
| MXPA05003881A (es) | Preparacion de compuestos triazospiro. | |
| TW200630369A (en) | Process for preparing purine compounds | |
| AU2002358557A1 (en) | Improved method for the production of biphosphites | |
| IL178228A0 (en) | A process for the semisynthesis of deserpidine | |
| SG155231A1 (en) | Process for synthesis of dialkoxyorganoboranes | |
| UA92613C2 (ru) | Способ получения кристаллической формы d эрбумина периндоприла |